Literature DB >> 12968361

Conjugating low molecular mass carbohydrates to proteins. 1. Monitoring the progress of conjugation.

Rina Saksena1, Anatoly Chernyak, Alex Karavanov, Pavol Kovác.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12968361     DOI： 10.1016/S0076-6879(03)01010-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  10 in total

1.  Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look.

Authors:  Peng Xu; Meagan Kelly; Willie F Vann; Firdausi Qadri; Edward T Ryan; Pavol Kováč
Journal:  Chembiochem       Date:  2017-03-23       Impact factor: 3.164

2.  Determination of glycation sites by tandem mass spectrometry in a synthetic lactose-bovine serum albumin conjugate, a vaccine model prepared by dialkyl squarate chemistry.

Authors:  Farid Jahouh; Shu-jie Hou; Pavol Kováč; Joseph H Banoub
Journal:  Rapid Commun Mass Spectrom       Date:  2012-04-15       Impact factor: 2.419

3.  Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant.

Authors:  Aileen F G Bongat; Rina Saksena; Roberto Adamo; Yukari Fujimoto; Zenyu Shiokawa; Dwight C Peterson; Koichi Fukase; Willie F Vann; Pavol Kovác
Journal:  Glycoconj J       Date:  2009-09-16       Impact factor: 2.916

4.  Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharides.

Authors:  Archana R Parameswar; In Ho Park; Rina Saksena; Pavol Kovác; Moon H Nahm; Alexei V Demchenko
Journal:  Chembiochem       Date:  2009-12-14       Impact factor: 3.164

5.  Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis spores.

Authors:  Andrea Kuehn; Pavol Kovác; Rina Saksena; Norbert Bannert; Silke R Klee; Heidrun Ranisch; Roland Grunow
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

6.  Preparation of glycoconjugates by dialkyl squarate chemistry revisited.

Authors:  Shu-Jie Hou; Rina Saksena; Pavol Kovác
Journal:  Carbohydr Res       Date:  2007-10-26       Impact factor: 2.104

7.  Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies.

Authors:  Michael D Meeks; Rina Saksena; Xingquan Ma; Terri K Wade; Ronald K Taylor; Pavol Kovác; William F Wade
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

8.  Immunogens related to the synthetic tetrasaccharide side chain of the Bacillus anthracis exosporium.

Authors:  Rina Saksena; Roberto Adamo; Pavol Kovác
Journal:  Bioorg Med Chem       Date:  2007-03-23       Impact factor: 3.641

9.  Mapping the glycation sites in the neoglycoconjugate from hexasaccharide antigen of Vibrio cholerae, serotype Ogawa and the recombinant tetanus toxin C-fragment carrier.

Authors:  Farid Jahouh; Peng Xu; Willie F Vann; Pavol Kováč; Joseph H Banoub
Journal:  J Mass Spectrom       Date:  2013-10       Impact factor: 1.982

10.  Revealing the glycation sites in synthetic neoglycoconjugates formed by conjugation of the antigenic monosaccharide hapten of Vibrio cholerae O1, serotype Ogawa with the BSA protein carrier using LC-ESI-QqTOF-MS/MS.

Authors:  Farid Jahouh; Rina Saksena; Pavol Kováč; Joseph Banoub
Journal:  J Mass Spectrom       Date:  2012-07       Impact factor: 1.982
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.